2025-2026 Regular Session • US Congress Legislature
HB2821: FDA Modernization Act 3.0
Legislative Summary
To require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to publish a final rule relating to nonclinical testing methods.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
4/10/2025
Introduced in House
House of Representatives
4/10/2025
Referred to the House Committee on Energy and Commerce.
House of Representatives
Status Information
Current Status
Introduced(4/10/2025)
Chamber
House of Representatives
Committee
Energy And Commerce(House of Representatives)
Sponsors
Republican: 7
Democrat: 5
Primary Sponsor
Earl Carter
Republican